DB17747ExperimentalProtein Based Therapies
Exbivirumab is an investigational monoclonal antibody. It is one of the active ingredients in HepeX-B, a drug product containing two human monoclonal antibodies to the hepatitis B virus (HBV) surface...
- Also known as
- HBV-Ab 19 · Immunoglobulin g, anti-(hepatitis b surface antigen) (human monoclonal 19.79.5 heavy chain), disulfide with human monoclonal 19.79.5 .lambda. chain, dimer
Resolves to
Compound
What you can answer from here — as of April 02, 2025
Which companies are running trials of Exbivirumab, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account